(PDF) P1.09-35 Clinical Impact of Systematic Inflammation

P1.09-35 Clinical Impact of Systematic Inflammation and Histologic Grade in Non Small Cell Lung Carcinoma (NSCLC)

Journal of Thoracic Oncology - United States

doi 10.1016/j.jtho.2018.08.811

Full Text

Abstract

Available in full text

Categories

Respiratory Medicine

Date

October 1, 2018

Authors

M. Galanopoulos

I. Gioulbasanis

Publisher

Elsevier BV

Related search

P1.09-36 Clinical Significance of Cannabinoid Receptor CB2 Expression in Non Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.08: Gene Fusions Detected in Non-Small Cell Lung Carcinoma (NSCLC) and Small Cell Lung Carcinoma (SCLC)

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.15-16 Clinical Economic Impact of Improved Genotyping in Patients With Advanced Non-Small Cell Lung Adenocarcinoma (NSCLC)

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.09-17 CTNNB1 (Beta-Catenin) Mutations in Non-Small Cell Lung Carcinoma: A Clinicopathological Study of 18 Cases

Journal of Thoracic Oncology

Respiratory Medicine

English

Clinical Response to Chemotherapy in Non-Small Cell Lung Carcinoma Patients

International Journal of Research in Medical Sciences

English

Checkpoint Inhibitors in Squamous Non-Small Cell Lung Cancer (NSCLC)

Open Access Journal of Oncology and Medicine

English

Functional Redundancy of HSPA1, HSPA2 and Other HSPA Proteins in Non-Small Cell Lung Carcinoma (NSCLC); An Implication for NSCLC Treatment

Scientific Reports

Multidisciplinary

English

P2.01-129 Potential Impact of KRAS Molecular Profiling of Non-Squamous Non-Small Cell Lung Cancer (NSCLC).

Journal of Thoracic Oncology

Respiratory Medicine

English

Cetuximab and Biomarkers in Non-Small-Cell Lung Carcinoma

Biologics: Targets and Therapy

Gastroenterology

English